ERYTECH Pharma announces appointment of Marc Beer to the Supervisory Board Post author:admERY Post published:February 17, 2011 Post category:Newsroom ERYTECH Pharma is pleased to welcome Marc Beer as a new board member. You Might Also Like ERYTECH adds a new product candidate to its Cancer Metabolism development portfolio April 9, 2014 ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting December 3, 2020 ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI December 13, 2021
ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting December 3, 2020
ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH Annual Meeting and Acceptance of Two Abstracts at ASCO GI December 13, 2021
